Search by keywords: Upcoming Seminars and Events View upcoming seminars and events. Learn more 553 News Items found In the Clinic Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days Tuesday, September 8, 2015 Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly. In the Lab New Chemical Biology Program Brings Power of Chemistry to Biomedical Research Tuesday, August 18, 2015 A new Sloan Kettering Institute program will enhance the use of chemical principles to investigate biological processes. In the Lab Manipulating a Single Gene Turns Colorectal Cancer Cells Back to Normal Wednesday, July 1, 2015 For the first time, scientists have shown that the gene APC, which is mutated in the vast majority of colorectal cancers, might be a promising target for future therapies. In the Lab Miniature Device Could Unlock the Promise of Some Kidney Cancer Drugs Monday, June 8, 2015 Memorial Sloan Kettering scientists have engineered a tiny particle that could ferry drugs directly to the kidneys and prevent their uptake in other organs. In the Lab Outsmarting Cancer’s Survival Skills Thursday, April 9, 2015 A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening. In the Clinic CAR T Cell Therapies Are a Growing Area of Research Tuesday, March 31, 2015 Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research. Q&A Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise Friday, January 30, 2015 An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. In the Lab Seeing the Light: How Engineered Nerve Cells Might Curb Parkinson’s Disease Thursday, January 22, 2015 A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells. In the Lab Investigators Use Stem Cells to Study Rare Pediatric Brain Tumors Monday, December 1, 2014 Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture. Finding Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs Monday, November 17, 2014 A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors. Pagination Load More